Indication

Attention-deficit hyperactivity disorder

Attention-deficit hyperactivity disorder is a chronic neurodevelopmental disorder of the central nervous system that originates in childhood and frequently persists into adulthood. Read more about Attention-deficit hyperactivity disorder

352 drugs 135 manufacturers

Advertisement

Drugs that treat it

Common Attention-deficit hyperactivity disorder therapies.

Showing 226–234 of 352 drugs

ATOMOXETINE HCL

ANTIDEPRESSANTS·ATTENTION-DEFICIT HYPERACTIVITY DISORDER
AVKARE

AMPHETAMINE SULFATE

AMPHETAMINES/ANOREXIANTS/STIMULANTS·ATTENTION-DEFICIT HYPERACTIVITY DISORDER·+2
SOLCO HEALTHCAR
Filter & compare in the drug finder →Opens the drug finder with Attention-deficit hyperactivity disorder preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Attention-deficit hyperactivity disorder.

Attention-deficit hyperactivity disorder is a chronic neurodevelopmental disorder of the central nervous system that originates in childhood and frequently persists into adulthood.

It is clinically characterized by a persistent and developmentally inappropriate pattern of inattention, hyperactivity, and impulsivity that causes significant functional impairment across multiple settings.

Pathophysiologically, the condition is associated with dysregulation of frontal-striatal neural circuits and altered catecholaminergic neurotransmission, particularly involving dopamine and norepinephrine pathways that govern executive function, behavioral inhibition, and sustained attention.

Personalize your experience

Follow Attention-deficit hyperactivity disorder and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it